Johns Hopkins University

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Johns Hopkins University sits in the top decile of US sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count).

1,448 total trials 250 currently recruiting 943 completed early-phase tilt top decile by trial count

Johns Hopkins University: 1,448 sponsored US clinical trials, 250 recruiting.

Johns Hopkins University sponsors 1,448 registered US clinical trials on ClinicalTrials.gov, 250 of them currently recruiting, and 943 completed. 125 of these trials are in Phase 3-4 (later-stage) and 399 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypertension, with 15 trials.

Top-decile sponsor footprint

Johns Hopkins University ranks in the top decile of sponsors by registered trial count (#14 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,448 total, page 9 of 29

COMPLETED Early Phase 1

Everolimus Trial in Laryngotracheal Stenosis

NCT05153668

COMPLETED NA

Ablation at Virtual-hEart pRedicted Targets for VT

NCT03536052

COMPLETED NA

Breast and Cervical Cancer Education Program

NCT06365450

COMPLETED NA

ARMS: The Arm Rest and Support Study

NCT05372328

COMPLETED NA

Determining Change In Blood Pressure Due to Environment and Loudness

NCT05394376

COMPLETED NA

Thriving Together: Supporting Resilience in the Healthcare Workforce

NCT05321381

COMPLETED Phase 3

Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension

NCT04039464

COMPLETED Phase 1

Acute Pharmacokinetic and Pharmacodynamic Effects of "Tobacco-Free" Oral Nicotine Pouches in Smokers

NCT05335915

COMPLETED NA

Self-Management of Chronic Low Back Pain: Targeting Patient Activation

NCT06236529

COMPLETED NA

Family Diabetes Prevention Program Pilot Study

NCT05358444

COMPLETED Phase 1

Effects of Psilocybin in Post-Treatment Lyme Disease

NCT05305105

COMPLETED NA

Virtual Group Psychoeducational Discussions With Spanish-Speaking Mothers of Infants in Pediatric Primary Care

NCT05423093

COMPLETED NA

Investigating Distress Tolerance in Adults With Tourette Syndrome

NCT05047705

COMPLETED NA

Implementation and Evaluation of a Diabetes Prevention Clinical Pathway in Primary Care

NCT05265312

COMPLETED Phase 1

Comparative Pharmacokinetic and Pharmacodynamic Effects of Delta-8 and Delta-9 THC

NCT05287256

COMPLETED

Bimanual Arm Training in Acute Stroke

NCT05106595

COMPLETED NA

Development of Discharge Education Video for Solid Organ Transplant Recipients

NCT05189340

COMPLETED NA

Making Health Care Safer for Older Adults Receiving Skilled Home Health Care Services After Hospital Discharge

NCT05182060

COMPLETED NA

Heart Failure Resilience Intervention for Caregivers

NCT03963583

TERMINATED Phase 2

Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care

NCT05366842

COMPLETED NA

Virtual Reality as a Substitute for Procedural Sedation During Epidural Steroid Injections

NCT04887285

TERMINATED Phase 4

Sodium Citrate 4% Locking Solution for Children Requiring Home Parenteral Nutrition

NCT04756427

TERMINATED NA

Pilot Study of reSET-O to Treatment-as-usual in Acute Care Settings

NCT04817267

COMPLETED NA

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

NCT05187117

COMPLETED

Glycemic Effects of the COVID-19 Booster Vaccine in Type 1 Diabetes

NCT05233592

COMPLETED Phase 1

The Pharmacokinetics and Pharmacodynamics of a Single Acute Dose of a Hemp-derived Oral Product With a 1:1 Ratio of CBD:CBD-A

NCT05049733

COMPLETED NA

MEMORI Corps: Activity-based Companion Care for Dementia

NCT03896711

TERMINATED

Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Dissection

NCT05236387

COMPLETED Early Phase 1

Reduced Nicotine Cigarette Purchasing Decisions

NCT04999644

COMPLETED Phase 1

The Impact of Oral Cannabis Administration and Co-Administration of Alcohol on Impairment

NCT04931095

COMPLETED NA

Patient Engagement in Perioperative Pain Management Project

NCT05252767

COMPLETED NA

Sound and Music for Mild Cognitive Impairment

NCT05064007

TERMINATED NA

Neodymium-doped Yttrium Aluminum Garnet (Nd:YAG) Laser Treatment for Granular Corneal Dystrophy

NCT06202651

COMPLETED NA

User-Led Meaningful Activity and Early-Stage Dementia

NCT05159869

COMPLETED Phase 4

Preventing Recurrent UTI With Vaginal Estrogen

NCT05551949

COMPLETED NA

Pilot Testing a Computer Delivered Tobacco Cessation Intervention in Outpatient Clinical Settings: A Feasibility Study

NCT05145738

COMPLETED NA

Radiofrequency Ablation of Papillary Thyroid Microcarcinoma

NCT05132205

COMPLETED Phase 2

Preventing Anaphylaxis With Acalabrutinib

NCT05038904

COMPLETED

Assessing Brain Injury Using Portable Magnetic Resonance Imaging (MRI)

NCT05469139

COMPLETED NA

ACCESS: AI for pediatriC diabetiC Eye examS Study

NCT05131451

COMPLETED NA

A Virtual Cardiometabolic Health Program for African Immigrants: The Afro-DPP Program

NCT05144737

COMPLETED NA

Leveraging Technological Advancements to Improve the Treatment of Trichotillomania

NCT05003401

COMPLETED NA

ACHIEVE Hearing Intervention Follow-Up Study

NCT05070429

COMPLETED NA

Anesthesia Counseling, Consent, & Professionalism

NCT06010836

COMPLETED NA

Comparing AlloDerm and DermACELL in Breast Reconstruction

NCT04710537

COMPLETED NA

Evaluation of a Tai Chi Resilience Training Program on Objective and Subjective Measures of Post Traumatic Stress Disorder Severity

NCT04288830

COMPLETED NA

Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation

NCT03846830

COMPLETED NA

Effectiveness and Cost-Effectiveness of Fully-Automated Digital vs. Human Coach-Based Diabetes Prevention Programs

NCT05056376

TERMINATED Phase 3

Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel

NCT04826484

TERMINATED Phase 2

Addition of Belimumab to B-cell Depletion in Relapsing-remitting Multiple Sclerosis

NCT04767698

← Previous Page 9 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 201
Phase 2 198
Phase 3 44
Phase 4 81

What is open in the Johns Hopkins University pipeline

250 recruiting of 1,448 indexed (17% open); 943 completed (65%).

Phase mix: 125 late (III/IV) vs 399 early (I/II) (early-phase heavy).

Top condition: Hypertension (15 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.